Earlier Primary Care Health Checks May Miss High-Risk Young Adults
England’s proposal to move the first NHS health check from age 40 to 30 is built on a simple idea: catch vascular risk earlier, before stroke or myocardial infarction arrives at the bedside. A population-based study from the Oxford Vascular Study suggests the strategy may still leave a large blind spot. In adults aged 30 to 44 years who went on to have an acute vascular event, most already carried modifiable risk factors, yet their premorbid 10-year cardiovascular risk estimates remained far below the level that would trigger active risk management under current thresholds.
The result creates a stark tension between biologic risk and calculator-driven eligibility. A younger person can accumulate hypertension, dyslipidemia, smoking exposure, or other treatable abnormalities long before a 10-year prediction model assigns a number high enough to unlock intervention.
Event Burden in the 30-to-44-Year Age Band
The analysis covered 94,567 people in a subpopulation of Oxfordshire, UK, with ascertainment running from 1 April 2002 through 31 March 2023. Across 433,797 person-years of follow-up, 217 individuals aged 30 to 44 years experienced an incident vascular event, corresponding to a crude incidence rate of 50 per 100,000 person-years. Those numbers matter because they show that vascular disease is not confined to older adulthood; it is already producing clinically meaningful event counts in a younger cohort often regarded as low risk.
The study then asked a narrower and more practical question: if the proposed earlier health check had been in place, who would have crossed the threshold for treatment? Of the 217 young adults with events, 155 would have been eligible for an earlier health check before their event based on a premorbid QRISK3 10-year absolute cardiovascular risk of at least 10%.
Why the 10-Year Threshold Fails Many Younger Patients
The threshold itself is the central weakness exposed by this dataset. Among those 155 eligible by age and risk-factor context, the median predicted 10-year cardiovascular risk was only 2.5%, with an interquartile range of 1.1% to 4.8%. Only 7 of the 155 reached or exceeded the 10% threshold for active risk management; 148, or 95%, fell below it. In women, the discrepancy was even sharper. The 49 women in this group had a median 10-year predicted risk of 1.1%, and none had a value above 10%.
This is the clinical trap: a short-term risk model can look reassuring precisely when cumulative vascular injury is already building. Younger adults have had fewer years to “earn” a high 10-year score, even if they have already accumulated risk factors that are physiologically important. In practice, that means the calculator may undercall the very patients in whom prevention would be most valuable.
Healthy-Heart Age Told a Different Story
A second metric in the analysis gave a less comforting readout. The mean predicted “healthy heart age” gap was 9 years, with a standard deviation of 7. In plain terms, the vascular profile of these adults often resembled that of someone nearly a decade older. This age gap matters because it translates abstract percentages into a concept patients and clinicians can immediately grasp: the arteries are aging faster than the calendar age suggests.
The same cohort also showed a heavy burden of treatable abnormalities. Among those with vascular events, 137 individuals, or 88%, had at least one risk factor above the recommended target level. This is the strongest bedside signal in the study. A young adult may not qualify for statin therapy, blood pressure treatment, or other preventive measures under a rigid 10-year threshold, yet the underlying risk-factor pattern is already abnormal and biologically active.
Prevention Strategy Needs to Look Beyond Short-Term Absolute Risk
The findings argue for a preventive framework that does not rely only on a 10-year absolute risk score in younger adults. Risk calculators are useful, but they are built to estimate near-term event probability, not cumulative lifetime vascular injury. In younger patients, the short horizon can work against prevention by pushing treatment below a cutoff until the first event has already occurred.
The biology is straightforward. Atherosclerosis develops over years under the influence of elevated blood pressure, smoking, lipids, glycemic burden, and other exposures. By the time a 30-something crosses a conventional 10-year threshold, some of the damage has already been established. Earlier health checks may still help, but if they are anchored too tightly to the same threshold used in older adults, they may detect risk without converting it into action.
Implications for the Proposed NHS Check at Age 30
England’s proposed reduction of the NHS health-check starting age from 40 to 30 is a meaningful policy shift, but this study suggests age alone will not solve the problem. Earlier assessment can identify risk factors, yet the current eligibility rule may still miss many younger adults who are on a path toward vascular events. The study’s data point to a mismatch between the age at which disease biology begins to matter and the age at which standard risk algorithms begin to recommend treatment.
The practical consequence is not subtle. If prevention hinges on a 10% 10-year risk threshold, many younger adults with clear risk-factor abnormalities will remain outside active management. The consequence is especially important for women, whose short-term risk estimates were uniformly below threshold in this event cohort despite subsequent vascular events.
What This Study Can and Cannot Prove
This was a population-based study from a defined UK region, not a randomized trial of an intervention policy. It shows that many young adults who later had vascular events would not have qualified for treatment under a 10-year absolute risk rule, even though most had at least one modifiable abnormality and a substantially older predicted heart age. It does not prove exactly which alternative threshold or policy would prevent the most events.
Still, the signal is hard to ignore. Younger adults with vascular events were rarely “low risk” in the biological sense; they were low risk in the accounting sense used by a short-term calculator. The study leaves health systems with a concrete problem: if prevention is expanded only by lowering the age of assessment, but not by revising how risk is judged in younger adults, many future strokes and other vascular events may remain outside the reach of routine primary care prevention.